Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03239392 |
Title | A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Bioniz Therapeutics |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope National Medical Center | Duarte | California | 10101 | United States | Details | |
Moffitt Cancer Center | Tampa | Florida | 33612 | United States | Details | |
The James Cancer Center, Ohio State University | Columbus | Ohio | 43210 | United States | Details | |
University of Virginia Cancer Center | Charlottesville | Virginia | 22908 | United States | Details |